Publications

Publications search (many options)

Publika data base

Publications (original articles or review articles) published in 2013 from OUS - Department of Pharmacology

31 publications found

Bach T, Bergholtz S, Riise J, Qvigstad E, Skomedal T, Osnes JB, Levy FO (2013)
Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure
Naunyn Schmiedebergs Arch Pharmacol, 387 (1), 5-14
PubMed 24297249

Brudeli B, Andressen KW, Moltzau LR, Nilsen NO, Levy FO, Klaveness J (2013)
Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists
Bioorg Med Chem, 21 (22), 7134-45
PubMed 24113240

Brudeli B, Moltzau LR, Nguyen CH, Andressen KW, Nilsen NO, Levy FO, Klaveness J (2013)
Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonist
Eur J Med Chem, 64, 629-37
PubMed 23711770

Dehnes Y, Shalina A, Myrvold L (2013)
Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections
Drug Test Anal, 5 (11-12), 861-9
PubMed 24190107

Eibye K, Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2013)
Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations
Med Sci Sports Exerc, 45 (1), 16-22
PubMed 22843108

Gellynck E, Heyninck K, Andressen KW, Haegeman G, Levy FO, Vanhoenacker P, Van Craenenbroeck K (2013)
The serotonin 5-HT7 receptors: two decades of research
Exp Brain Res, 230 (4), 555-68
PubMed 24042216

Gravning J, Ahmed MS, Qvigstad E, Krobert K, Edvardsen T, Moe IT, Hagelin EM, Sagave J, Valen G, Levy FO, Osnes JB, Skomedal T, Attramadal H (2013)
Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes
Mol Pharmacol, 84 (3), 372-83
PubMed 23778361

Gu GJ, Wu D, Lund H, Sunnemark D, Kvist AJ, Milner R, Eckersley S, Nilsson LN, Agerman K, Landegren U, Kamali-Moghaddam M (2013)
Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease
J Alzheimers Dis, 33 (3), 699-713
PubMed 23001711

Gumucio A, Lannfelt L, Nilsson LN (2013)
Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
BMC Neurosci, 14, 148
PubMed 24261309

Henning O, Baftiu A, Johannessen SI, Landmark CJ (2013)
Withdrawal of antiepileptic drugs during presurgical video-EEG monitoring: an observational study for evaluation of current practice at a referral center for epilepsy
Acta Neurol Scand, 129 (4), 243-51
PubMed 23980664

Hostrup M, Kalsen A, Auchenberg M, Rzeppa S, Hemmersbach P, Bangsbo J, Backer V (2013)
Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes
Drug Test Anal, 6 (6), 528-32
PubMed 24166762

Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird TD, Nochlin D, Schellenberg GD, Brundin R, Olofsson T, Soliymani R, Baumann M, Wirths O, Bayer TA, Nilsson LN, Basun H, Lannfelt L, Ingelsson M (2013)
The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ
Acta Neuropathol Commun, 1, 60
PubMed 24252272

Karouni M, Henning O, Larsson PG, Johannessen SI, Johannessen Landmark C (2013)
Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy
Epilepsy Behav, 29 (1), 77-81
PubMed 23939032

Kvehaugen AS, Melien Ø, Holmen OL, Laivuori H, Dechend R, Staff AC (2013)
PP084. Hypertension after preeclampsia in women with C1114G polymorphism in rgs2 (the regulator of g protein signaling 2)
Pregnancy Hypertens, 3 (2), 98
PubMed 26105937

Levay M, Krobert KA, Wittig K, Voigt N, Bermudez M, Wolber G, Dobrev D, Levy FO, Wieland T (2013)
NSC23766, a widely used inhibitor of Rac1 activation, additionally acts as a competitive antagonist at muscarinic acetylcholine receptors
J Pharmacol Exp Ther, 347 (1), 69-79
PubMed 23887096

Lillehaug S, Syverstad GH, Nilsson LN, Bjaalie JG, Leergaard TB, Torp R (2013)
Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice
Neurobiol Aging, 35 (3), 556-64
PubMed 24126157

Lillenes MS, Støen M, Gómez-Muñoz M, Torp R, Günther CC, Nilsson LN, Tønjum T (2013)
Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model
Mech Ageing Dev, 134 (10), 467-77
PubMed 24121118

Lund H, Snilsberg AH, Halvorsen TG, Hemmersbach P, Reubsaet L (2013)
Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis
Bioanalysis, 5 (5), 623-30
PubMed 23425277

Lærum H, Bremer S, Bergan S, Grünfeld T (2013)
A taste of individualized medicine: physicians' reactions to automated genetic interpretations
J Am Med Inform Assoc, 21 (e1), e143-6
PubMed 24001515

Magnusson K, Sehlin D, Syvänen S, Svedberg MM, Philipson O, Söderberg L, Tegerstedt K, Holmquist M, Gellerfors P, Tolmachev V, Antoni G, Lannfelt L, Hall H, Nilsson LN (2013)
Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain
J Alzheimers Dis, 37 (1), 29-40
PubMed 23780660

Martinov V, Dehnes Y, Holmseth S, Shimamoto K, Danbolt NC, Valen G (2013)
A novel glutamate transporter blocker, LL-TBOA, attenuates ischaemic injury in the isolated, perfused rat heart despite low transporter levels
Eur J Cardiothorac Surg, 45 (4), 710-6
PubMed 24099732

Molenaar P, Christ T, Hussain RI, Engel A, Berk E, Gillette KT, Chen L, Galindo-Tovar A, Krobert KA, Ravens U, Levy FO, Kaumann AJ (2013)
PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients
Br J Pharmacol, 169 (3), 528-38
PubMed 23489141

Moltzau LR, Aronsen JM, Meier S, Nguyen CH, Hougen K, Ørstavik Ø, Sjaastad I, Christensen G, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2013)
SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium
Br J Pharmacol, 170 (2), 366-79
PubMed 23808942

Narum S, Solhaug V, Myhr K, Brørs O, Kringen MK (2013)
Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system
Eur J Clin Pharmacol, 69 (7), 1445-52
PubMed 23423243

Reine PA, Vethe NT, Kongsgaard UE, Andersen AM, Line PD, Ali AM, Bergan S (2013)
Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring
Scand J Clin Lab Invest, 73 (2), 117-24
PubMed 23281843

Rogeberg M, Malerod H, Roberg-Larsen H, Aass C, Wilson SR (2013)
On-line solid phase extraction-liquid chromatography, with emphasis on modern bioanalysis and miniaturized systems
J Pharm Biomed Anal, 87, 120-9
PubMed 23746991

Skarstein S, Rosvold EO, Helseth S, Kvarme LG, Holager T, Småstuen MC, Lagerløv P (2013)
High-frequency use of over-the-counter analgesics among adolescents: reflections of an emerging difficult life, a cross-sectional study
Scand J Caring Sci, 28 (1), 49-56
PubMed 23517110

Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK (2013)
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
PubMed 23580084

Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
Importance of hematocrit for a tacrolimus target concentration strategy
Eur J Clin Pharmacol, 70 (1), 65-77
PubMed 24071959

Sørensen O, Andersen AM, Kristian A, Giercksky KE, Flatmark K (2013)
Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis
J Surg Oncol, 109 (6), 521-6
PubMed 24347444

Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Transpl Int, 26 (12), 1198-207
PubMed 24118301